Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 147.61 Million CNY | 51.62% |
| 2022 | 97.35 Million CNY | 21.38% |
| 2021 | 80.2 Million CNY | -41.11% |
| 2020 | 136.19 Million CNY | 119.46% |
| 2019 | 62.05 Million CNY | 115.38% |
| 2018 | 28.81 Million CNY | -38.74% |
| 2017 | 47.03 Million CNY | -24.34% |
| 2016 | 62.16 Million CNY | 38.35% |
| 2015 | 44.93 Million CNY | -16.18% |
| 2014 | 53.6 Million CNY | -16.33% |
| 2013 | 64.07 Million CNY | -13.26% |
| 2012 | 73.86 Million CNY | 36.87% |
| 2011 | 53.96 Million CNY | 39.85% |
| 2010 | 38.59 Million CNY | 33.27% |
| 2009 | 28.95 Million CNY | 16.73% |
| 2008 | 24.8 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 16.78 Million CNY | 99.33% |
| 2024 Q1 | 38.1 Million CNY | 53.56% |
| 2024 Q2 | 8.41 Million CNY | -77.91% |
| 2023 Q2 | 41.75 Million CNY | -16.52% |
| 2023 Q3 | 31.01 Million CNY | -25.72% |
| 2023 Q4 | 24.81 Million CNY | -20.0% |
| 2023 FY | 147.61 Million CNY | 51.62% |
| 2023 Q1 | 50.01 Million CNY | 131.79% |
| 2022 Q1 | 9.58 Million CNY | -25.03% |
| 2022 Q4 | 21.57 Million CNY | -46.16% |
| 2022 Q2 | 26.32 Million CNY | 174.65% |
| 2022 Q3 | 40.08 Million CNY | 52.23% |
| 2022 FY | 97.35 Million CNY | 21.38% |
| 2021 Q3 | 203.96 Thousand CNY | -99.55% |
| 2021 Q4 | 12.78 Million CNY | 6169.15% |
| 2021 Q1 | 22 Million CNY | 128.61% |
| 2021 FY | 80.2 Million CNY | -41.11% |
| 2021 Q2 | 45.21 Million CNY | 105.49% |
| 2020 FY | 136.19 Million CNY | 119.46% |
| 2020 Q3 | 69.5 Million CNY | 63.72% |
| 2020 Q2 | 42.45 Million CNY | 190.57% |
| 2020 Q4 | 9.62 Million CNY | -86.15% |
| 2020 Q1 | 14.61 Million CNY | -32.71% |
| 2019 Q2 | 10.08 Million CNY | 3.31% |
| 2019 Q4 | 21.71 Million CNY | 5.92% |
| 2019 FY | 62.05 Million CNY | 115.38% |
| 2019 Q1 | 9.76 Million CNY | 212.28% |
| 2019 Q3 | 20.49 Million CNY | 103.3% |
| 2018 Q4 | -8.69 Million CNY | -170.86% |
| 2018 FY | 28.81 Million CNY | -38.74% |
| 2018 Q2 | 10.28 Million CNY | -31.2% |
| 2018 Q1 | 14.95 Million CNY | 567.23% |
| 2018 Q3 | 12.26 Million CNY | 19.27% |
| 2017 Q3 | 12.39 Million CNY | -29.92% |
| 2017 Q4 | -3.2 Million CNY | -125.82% |
| 2017 Q2 | 17.68 Million CNY | -12.26% |
| 2017 FY | 47.03 Million CNY | -24.34% |
| 2017 Q1 | 20.15 Million CNY | 35.92% |
| 2016 FY | 62.16 Million CNY | 38.35% |
| 2016 Q2 | 13.13 Million CNY | -27.28% |
| 2016 Q1 | 18.06 Million CNY | 96.5% |
| 2016 Q3 | 16.14 Million CNY | 22.9% |
| 2016 Q4 | 14.82 Million CNY | -8.14% |
| 2015 Q2 | 10.16 Million CNY | -39.73% |
| 2015 FY | 44.93 Million CNY | -16.18% |
| 2015 Q4 | 9.19 Million CNY | 5.39% |
| 2015 Q1 | 16.85 Million CNY | -0.56% |
| 2015 Q3 | 8.72 Million CNY | -14.17% |
| 2014 Q4 | 16.95 Million CNY | 90.62% |
| 2014 Q2 | 11.89 Million CNY | -25.03% |
| 2014 Q1 | 15.86 Million CNY | -8.11% |
| 2014 FY | 53.6 Million CNY | -16.33% |
| 2014 Q3 | 8.89 Million CNY | -25.22% |
| 2013 Q3 | 10 Million CNY | -29.41% |
| 2013 Q1 | 22.62 Million CNY | 12.39% |
| 2013 FY | 64.07 Million CNY | -13.26% |
| 2013 Q4 | 17.26 Million CNY | 72.54% |
| 2013 Q2 | 14.17 Million CNY | -37.35% |
| 2012 FY | 73.86 Million CNY | 36.87% |
| 2012 Q4 | 20.13 Million CNY | 5.65% |
| 2012 Q3 | 19.05 Million CNY | 33.41% |
| 2012 Q2 | 14.28 Million CNY | -29.97% |
| 2012 Q1 | 20.39 Million CNY | -11.04% |
| 2011 Q1 | 9.84 Million CNY | 0.0% |
| 2011 FY | 53.96 Million CNY | 39.85% |
| 2011 Q2 | 8.13 Million CNY | -17.4% |
| 2011 Q3 | 13.05 Million CNY | 60.56% |
| 2011 Q4 | 22.92 Million CNY | 75.56% |
| 2010 FY | 38.59 Million CNY | 33.27% |
| 2009 FY | 28.95 Million CNY | 16.73% |
| 2008 FY | 24.8 Million CNY | 0.0% |